Inhibition of interleukin 1 synthesis by tenidap: A new drug for arthritis
Authors:
- Marcia L. BlivenMBMarcia L. Bliven
- James T. DownsJDJames T. Downs
- Edward J. NatoliENEdward J. Natoli
- Douglas C. HansonDHDouglas C. Hanson
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Reduction of biological activity of murine recombinant interleukin‐1β by selective deamidation at asparagine‐149FEBS Letters, 1991
- Isolation and characterization of biologically active murine interleukin-1α derived from expression of a synthetic gene in Escherichia coliBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1989
- Effects of continuously administered murine interleukin-1 alpha: tolerance development and granuloma formationInfection and Immunity, 1989
- Effects of murine recombinant interleukin 1 on intact homologous articular cartilage: a quantitative and autoradiographic study.Annals of the Rheumatic Diseases, 1988
- The effects of continuous administration of murine interleukin-1α in the ratPhysiology & Behavior, 1988
- Interleukin-1-like activities in synovial fluids of patients with rheumatoid arthritis and traumatic synovitisRheumatology International, 1985
- Cloning and expression of murine interleukin-1 cDNA in Escherichia coliNature, 1984
- The influence of lipoxygenase inhibitors on the in vitro production of human leukocytic pyrogen and lymphocyte activating factor (interleukin-1)International Journal of Immunopharmacology, 1984
- Isolation of an interleukin‐1‐like factor from human joint effusionsArthritis & Rheumatism, 1983
- A cartilage catabolic factor from synoviumBiochemical Journal, 1979